News & Updates

Show Multimedia Only
Longer time in BP target protects against adverse cardiovascular events in diabetes

Longer time in BP target protects against adverse cardiovascular events in diabetes

08 Mar 2023

For patients with hypertension and diabetes, longer time spent in blood pressure (BP) target range helps lower the risk of cardiovascular disease, according to a study.

08 Mar 2023
GLP-1 RAs vs SGLT2 inhibitors: What are the comparative risks of ischaemic stroke and incident AF?

GLP-1 RAs vs SGLT2 inhibitors: What are the comparative risks of ischaemic stroke and incident AF?

08 Mar 2023 byNatalia Reoutova

A population-based retrospective study of Hong Kong patients with type 2 diabetes (T2D) finds that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a lower risk of ischaemic stroke, while use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with a lower risk of atrial fibrillation (AF).

08 Mar 2023
HPV infection ups CVD risk, but not in vaccinated women

HPV infection ups CVD risk, but not in vaccinated women

02 Mar 2023

Human papillomavirus (HPV) infection appears to be a risk factor for cardiovascular diseases (CVDs), suggests a recent study. However, women vaccinated against HPV are protected against such risk.

02 Mar 2023